Tele-Support for Emergency Medical Technicians (POHCA)

April 9, 2024 updated by: Christina Hafner, Medical University of Vienna

Tele-Support for Emergency Medical Technicians Dealing With Pediatric Cardiac Arrest: a Randomized, Simulation-based Study

In this manikin-based simulation study the impact of tele-support during a simulated pediatric out-of-hospital cardiac arrest scenario on emergency medical technicians' guideline adherence, on gaze behavior as well as on performance of resuscitation management and cognitive load will be analyzed.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

80 emergency medical technicians (EMT) will take part in this simulation study. The participants will be confronted with a scenario of an 8-year old boy, while wearing eye tracking glasses. In a parallel group design, the teams will be randomly assigned to a group performing advanced life support (ALS) without further support (group 1) or with additional tele-support (group 2). In case of support, an emergency physician assists the team performing the cardiopulmonary resuscitation management via a real-time remote connection.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Vienna, Austria, 1090
        • Recruiting
        • Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-65 years
  • Active work as an emergency medical technician

Exclusion Criteria:

  • Pregnancy
  • Prior knowledge of study setting or simulation scenario

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No-Support
Participants randomized to Group 1 will perform the simulation scenario without tele-support.
Other: Tele-Support
Participants randomized to Group 2 will perform the simulation scenario with tele-support.
via real-time audio-video connection through an experienced physician

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
guideline adherence
Time Frame: Day 1
checklist (scale of 0-15 points)
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gaze behavior
Time Frame: Day 1
dwell time in predefined areas of interest and fixation count
Day 1
teamwork performance
Time Frame: Day 1
Team Emergency Assessment Measure (11 items on scale 0-4 for components leadership, team work and task management resulting in a total score with scale 0-44; scale 1-10 for overall global rating)
Day 1
cognitive load
Time Frame: Day 1
NASA Taskload Index (scale of 0-20 points)
Day 1
Performance of cardiopulmonary resuscitation
Time Frame: Day 1
Chest compressions (time to 1st compression, depth, frequency, total hands-off period); defibrillator: time to 1st rhythm analysis; ventilation: time to 1st ventilation, airway management; intravenous access: time to drug application; reversible causes: time to discussing potential reversible causes for cardiac arrest
Day 1
Technical feasibility
Time Frame: Day 1
time of detection of visual attention through eye-tracking glasses
Day 1
Usability
Time Frame: Day 1
Questionnaire (5-point Likert scale) on usability of tele-support and eye-tracking glasses
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christina Hafner, MD, PhD, Medical University of Vienna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2024

Primary Completion (Estimated)

April 18, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

April 3, 2024

First Submitted That Met QC Criteria

April 9, 2024

First Posted (Actual)

April 12, 2024

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 9, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not a plan to make IPD available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on Tele-support

3
Subscribe